Pliant Therapeutics Inc Cash Flow Reinvestment Rate
Latest as of June 2020:
13.72x
Pliant Therapeutics Inc cash flow reinvestment rate. Pliant Therapeutics Inc (PLRX) has a Cash Flow Reinvestment Rate of 13.72x as of June 2020, reinvesting $106.61 Million (capex $286.00K plus investments $-106.32 Million) from operating cash flow of $7.77 Million. Explore Pliant Therapeutics Inc debt service capacity to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
13.72x
(Capex + Investments) / Operating CF
Total Reinvested
$106.61 Million
Capex + Investments
Operating Cash Flow
$7.77 Million
USD
Capital Expenditures
$286.00K
USD
Pliant Therapeutics Inc Cash Flow Reinvestment Rate by Year (None–None)
Pliant Therapeutics Inc cash flow reinvestment rate by year from None to None. Year-by-year capital reinvestment analysis for Pliant Therapeutics Inc. For the full cash flow conversion analysis, see PLRX cash flow metrics.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow